Dr. Kathleen Carroll is the Albert E. Kent Professor of Psychiatry at Yale University School of Medicine and Principal Investigator of the Psychotherapy Development Center as well as Principal Investigator of the New England Node of the Clinical Trials Network, both funded by the National Institute on Drug Abuse (NIDA).
Carroll graduated summa cum laude from Duke University, received her Ph.D. in clinical psychology in 1988 from the University of Minnesota, and completed her pre-doctoral training at the Yale University School of Medicine’s Division of Substance Abuse, where she was promoted to Professor in 2002. Since 1994 she has served as Scientific Director of the Center for Psychotherapy Development at Yale, NIDA’s only Center devoted to behavioral therapies research, and since 1999 she has been Principal Investigator of the New England Node of the National Institute on Drug Abuse’s Clinical Trials Network. An ISI Thompson ISI Highly Cited Researcher, Dr. Carroll is the author of over 220 peer-reviewed publications as well as numerous chapters and books.
Her research has focused on the development and evaluation of behavioral treatments and combinations of behavioral therapies and pharmacotherapies, with an emphasis on improving the quality and rigor of clinical efficacy research in the addictions. Dr. Carroll received a NIH MERIT (Method to Extend Research in Time) in 2003 for her work on developing computer-assisted training in cognitive-behavioral therapy. Dr. Carroll served as President of the American Psychological Association’s Division 50 (Addictions) from 2002-2005 and received the Divisions’ Distinguished Scientific Contributions to Education and Training Award in 2005.